We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You canĀ read more about our cookies before you choose.
Infliximab for refractory or progressive neurosarcoidosis (adults and post-pubescent children)
Infliximab will be available as a treatment option through routine commissioning for refractory or progressive neurosarcoidosis within the criteria set out in this document.